Manulife (Manufacturers Life Insurance)’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-39,318
| Closed | -$1.85M | – | 2993 |
|
|
2025
Q2 | $1.85M | Sell |
39,318
-65,899
| -63% | -$2.93M | ﹤0.01% | 1531 |
|
|
2025
Q1 | $4.64M | Sell |
105,217
-302,466
| -74% | -$13.9M | ﹤0.01% | 1196 |
|
|
2024
Q4 | $14.7M | Buy |
407,683
+122,128
| +43% | +$4.27M | 0.01% | 722 |
|
|
2024
Q3 | $9.15M | Buy |
285,555
+162,137
| +131% | +$6.06M | 0.01% | 929 |
|
|
2024
Q2 | $4.65M | Sell |
123,418
-21,611
| -15% | -$910K | ﹤0.01% | 1199 |
|
|
2024
Q1 | $7.14M | Buy |
145,029
+35,645
| +33% | +$1.65M | 0.01% | 1029 |
|
|
2023
Q4 | $3.99M | Buy |
109,384
+23,942
| +28% | +$625K | ﹤0.01% | 1241 |
|
|
2023
Q3 | $1.98M | Buy |
85,442
+10,359
| +14% | +$283K | ﹤0.01% | 1438 |
|
|
2023
Q2 | $1.97M | Buy |
75,083
+40,238
| +115% | +$1.06M | ﹤0.01% | 1417 |
|
|
2023
Q1 | $897K | Buy |
34,845
+224
| +0.6% | +$6.55K | ﹤0.01% | 1692 |
|
|
2022
Q4 | $868K | Buy |
34,621
+585
| +2% | +$14.4K | ﹤0.01% | 1680 |
|
|
2022
Q3 | $944K | Sell |
34,036
-290
| -0.8% | -$8.31K | ﹤0.01% | 1633 |
|
|
2022
Q2 | $862K | Buy |
34,326
+6,459
| +23% | +$236K | ﹤0.01% | 1712 |
|
|
2022
Q1 | $1.62M | Buy |
27,867
+12,619
| +83% | +$722K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $948 | Sell |
15,248
-28
| -0.2% | -$1.85K | ﹤0.01% | 1864 |
|
|
2021
Q3 | $969K | Sell |
15,276
-1,532
| -9% | -$118K | ﹤0.01% | 1863 |
|
|
2021
Q2 | $1.39M | Buy |
16,808
+2,941
| +21% | +$223K | ﹤0.01% | 1793 |
|
|
2021
Q1 | $1.02M | Sell |
13,867
-768
| -5% | -$60.1K | ﹤0.01% | 1865 |
|
|
2020
Q4 | $1.06M | Buy |
14,635
+1,716
| +13% | +$110K | ﹤0.01% | 1781 |
|
|
2020
Q3 | $616K | Sell |
12,919
-200
| -2% | -$8.52K | ﹤0.01% | 1888 |
|
|
2020
Q2 | $551K | Buy |
13,119
+5,712
| +77% | +$203K | ﹤0.01% | 1914 |
|
|
2020
Q1 | $200K | Buy |
+7,407
| New | +$241K | ﹤0.01% | 2324 |
|
Other funds holding SWTX
Manulife (Manufacturers Life Insurance)'s SWTX Position: Q3 2025 in Review
Manulife (Manufacturers Life Insurance) sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 39,318 shares — an estimated $1.85M sold.
Manulife (Manufacturers Life Insurance) first reported a position in SWTX in Q1 2020 and held it in 22 quarters. The position peaked at $14.7M in Q4 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Manulife (Manufacturers Life Insurance) reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 39,318 SpringWorks Therapeutics shares in Q3 2025, an estimated $1.85M.
- Manulife (Manufacturers Life Insurance) first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 22 quarters.
- Manulife (Manufacturers Life Insurance)'s SpringWorks Therapeutics position peaked at $14.7M in Q4 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.